Evaluation of efficacy and safety of evolocumab 140 mg in genetically characterized He-Fh patientsG. Bruzzone, P. Lopena, G. Balleari,A. Pasta,P. Dapino,R. Fresa,A. Pende,F. Dallegri,L. PisciottaEUROPEAN JOURNAL OF CLINICAL INVESTIGATION(2017)引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要